As the field of cell therapy evolves, integrating the latest technologies and robust analytical methods has never been more crucial. Join us at the 6th Cell Therapy Analytical Development Summit to discover how to enhance your analytical strategies and accelerate product development through IND and clinical trials, leading to more efficient regulatory approval.

Why Attend?

• Explore the latest advancements in immunophenotype, cell-based, and molecular assays.
• Connect with over 40 industry leaders and experts from companies like Bristol Myers Squibb, Takeda, and Kite Pharma to delve into assay matrices, phase-appropriate development, and specifications.
• Participate in discussions on overcoming challenges in product characterization, assay development, and scale-up, sharing innovative technologies and best practices to advance cell therapies.

Join us to elevate the development of safe and effective autologous and allogeneic cell therapies to new heights!

Download the NEW 2024 program